|
MTCP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.41875400316849E-12 |
| Normal-vs-Stage2 |
4.48089998439372E-09 |
| Normal-vs-Stage3 |
4.78506123613442E-13 |
| Normal-vs-Stage4 |
2.91777713101737E-12 |
| Stage1-vs-Stage2 |
2.310800E-01 |
| Stage1-vs-Stage3 |
2.996300E-02 |
| Stage1-vs-Stage4 |
2.960100E-03 |
| Stage2-vs-Stage3 |
7.034400E-01 |
| Stage2-vs-Stage4 |
1.611800E-01 |
| Stage3-vs-Stage4 |
2.385400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.55191440096314E-15 |
| Normal-vs-AfricanAmerican |
1.81296999999248E-05 |
| Normal-vs-Asian |
4.13209999999831E-05 |
| Caucasian-vs-AfricanAmerican |
7.809600E-01 |
| Caucasian-vs-Asian |
1.464620E-01 |
| AfricanAmerican-vs-Asian |
3.228600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.13464793116691E-13 |
| Normal-vs-Female |
1.64612767861172E-12 |
| Male-vs-Female |
1.720390E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.28357349591124E-12 |
| Normal-vs-Age(41-60Yrs) |
2.74991140969405E-12 |
| Normal-vs-Age(61-80Yrs) |
2.46946907367374E-12 |
| Normal-vs-Age(81-100Yrs) |
3.84210000000662E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.648000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.943600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.902300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.896390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.694630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.663800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.246790E-04 |
| Classical-VS-Follicular |
2.688100E-02 |
| Classical-VS-Other |
9.662800E-01 |
| Classical-VS-Normal |
2.62334598488678E-12 |
| Tall-VS-Follicular |
7.213600E-02 |
| Tall-VS-Other |
2.695000E-01 |
| Tall-VS-Normal |
9.4091401336982E-13 |
| Follicular-VS-Other |
5.417800E-01 |
| Follicular-VS-Normal |
4.0771053200217E-11 |
| Other-VS-Normal |
1.631580E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.60045326885938E-13 |
| Normal-vs-N1 |
8.94310000498777E-08 |
| N0-vs-N1 |
6.657400E-01 |
|
|
